Liu, Zhaoguo <br/><br/>
Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.  [electronic resource] 

 -  International immunopharmacology  Jun 2016 
 - 210-216 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2016.04.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists--therapeutic use<br/>Animals<br/>Anti-Inflammatory Agents--therapeutic use<br/>Bungarotoxins--administration & dosage<br/>Dexmedetomidine--therapeutic use<br/>Interleukin-6--genetics<br/>Lipopolysaccharides--immunology<br/>Lung--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>NF-kappa B--metabolism<br/>Pneumonia--drug therapy<br/>Sepsis--drug therapy<br/>Signal Transduction--drug effects<br/>Tumor Necrosis Factor-alpha--genetics<br/>alpha7 Nicotinic Acetylcholine Receptor--antagonists & inhibitors